Voltage-Gated Potassium Channel Kv1.3 Is Highly Expressed in Human Osteosarcoma and Promotes Osteosarcoma Growth

Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention

(2012) A. Felipe et al.   CURRENT MEDICINAL CHEMISTRY

Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells

(2012) Luigi Leanza et al.   EMBO Molecular Medicine

Short Hairpin RNA (shRNA) Ether à go-go 1 (Eag1) Inhibition of Human Osteosarcoma Angiogenesis via VEGF/PI3K/AKT Signaling

(2012) Jin Wu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Kv1.3 voltage-gated K+ channel subunit as a potential diagnostic marker and therapeutic target for breast cancer

(2011) Soo-Hwa Jang et al.   BMB Reports

Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo

(2010) Soo Hwa Jang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Contribution of voltage-gated potassium channels to the regulation of apoptosis

(2010) Ildikò Szabò et al.   FEBS LETTERS

Kv1.3: The perfect opening of the platelet voltage gate

(2010) Michael Emerson   JOURNAL OF PHYSIOLOGY-LONDON

Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer

(2009) J. Bielanska et al.   CURRENT CANCER DRUG TARGETS

The functional network of ion channels in T lymphocytes

(2009) Michael D. Cahalan et al.   IMMUNOLOGICAL REVIEWS

Primary Osteogenic Sarcoma with Pulmonary Metastasis: Clinical Results and Prognostic Factors in 91 Patients

(2009) P. K. Wu et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes

(2008) I. Szabo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA